ID

17300

Descripción

Efficacy and Safety of Insulin Detemir in Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00595374

Link

https://clinicaltrials.gov/show/NCT00595374

Palabras clave

Versiones (1)
  1. 5/9/16 5/9/16 -
Subido en

5 de septiembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes NCT00595374

Inglés

Eligibility Diabetes NCT00595374

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00595374
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
duration of type 1 diabetes for at least 12 months
Descripción

Insulin-Dependent Diabetes Mellitus disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
bmi below 35 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
hba1c between 7.0-12.0%
Descripción

Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
current treatment with preprandial short acting insulin and insulin nph once or twice daily for at least 6 months
Descripción

Short-Acting Insulin ante cibus U/day | insulin isophane U/day

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0356365
UMLS CUI [1,2]
C1550738
UMLS CUI [1,3]
C0456683
UMLS CUI [2,1]
C0021658
UMLS CUI [2,2]
C0456683
fertile females must use acceptable method of contraception if there is any risk of pregnancy in the opinion of the investigator
Descripción

Childbearing Potential Contraceptive methods | Risk of Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2]
C4048193
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known or suspected allergy to trial product or related products
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439849
UMLS CUI [2,4]
C0013230
previous participation in this trial
Descripción

Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
receipt of any investigational products within the last 2 months prior to this trial
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
drug or alcohol dependence
Descripción

Substance Dependence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038580
pregnancy, breast-feeding or intention of becoming pregnant
Descripción

Pregnancy | Breast Feeding | Pregnancy, Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
Volver a la parte superior de la página

Similar models

Eligibility Diabetes NCT00595374

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00595374
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Insulin-Dependent Diabetes Mellitus disease length
Item
duration of type 1 diabetes for at least 12 months
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Body mass index
Item
bmi below 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hba1c between 7.0-12.0%
boolean
C0019018 (UMLS CUI [1])
Short-Acting Insulin ante cibus U/day | insulin isophane U/day
Item
current treatment with preprandial short acting insulin and insulin nph once or twice daily for at least 6 months
boolean
C0356365 (UMLS CUI [1,1])
C1550738 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
C0021658 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods | Risk of Pregnancy
Item
fertile females must use acceptable method of contraception if there is any risk of pregnancy in the opinion of the investigator
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C4048193 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity Investigational New Drugs | Hypersensitivity Pharmaceutical Preparations Related Investigational New Drugs
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
Study Subject Participation Status
Item
previous participation in this trial
boolean
C2348568 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of any investigational products within the last 2 months prior to this trial
boolean
C0013230 (UMLS CUI [1])
Substance Dependence
Item
drug or alcohol dependence
boolean
C0038580 (UMLS CUI [1])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
pregnancy, breast-feeding or intention of becoming pregnant
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial